Norfolk Community Services Board- Tidewater Drive

Norfolk Community Services Board- Tidewater Drive is a SAMHSA-registered addiction-treatment facility in Bremerton, WA. The specific care levels offered by Norfolk Community Services Board- Tidewater Drive should be confirmed directly with the admissions team. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Norfolk Community Services Board- Tidewater Drive

Care-level specifics for Norfolk Community Services Board- Tidewater Drive are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. ASAM Criteria 4e is the benchmark framework for matching patients to appropriate intensity. Most major payer medical-necessity documents reference it. An outside ASAM-aligned assessment, prior to admission, is the protection against misplacement.

Insurance and payment

Payment and insurance specifics for Norfolk Community Services Board- Tidewater Drive are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The operational prerequisite is written documentation: in-network status for your specific plan product, deductible accumulation, coinsurance rate, prior-authorization status. Admissions without these four documented carry material risk of post-admission financial disagreement.

Before you call

The operational due diligence on Norfolk Community Services Board- Tidewater Drive comes down to three documents: ASAM-aligned level-of-care documentation matching independent clinical assessment, written Verification of Benefits for your specific plan product, written MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Norfolk Community Services Board- Tidewater Drive offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.